OptimizeRx (NASDAQ:OPRX) Issues Earnings Results, Beats Expectations By $0.17 EPS
OptimizeRx (NASDAQ:OPRX – Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.03 by $0.17. OptimizeRx had a positive return on equity of 4.50% and a negative net margin of 9.42%.The business had revenue of $26.07 million during the quarter, compared to analyst estimates of $23.83 million.
Source link